Published: 13-01-2022 13:56 | Updated: 13-01-2022 13:58

Current calls, week 2, 2022

Tips from Grants Office regarding current calls

Swedish and Nordic calls

Grants for medical research – Petrus and Augustus Hedlund Foundation

These promote medical research in the areas of brain diseases and psychiatry as well as infection and chronic inflammatory diseases. Funding is worth up to approximately SEK 5 million and projects may last for up to three years.

Closing date: 31 January 2022

Further information 


Large research grant – Hjärt-Lungfonden

This aims to create conditions for crucial research breakthroughs within cardiovascular research as well as national coordinated intervention studies and medical informatics. Grants are worth up to SEK 5 million per year for up to three years.

Closing date: 9 February 2022

Further information


Postdoc anslag och anslag för forskningsvistelse – IF Stiftelse

IF stiftelse för farmaceutisk forskning, som förvaltas av Apotekarsocieteten, har till ändamål att främja studier, forskning och undervisning inom farmacins vetenskapsområden genom anslag och stipendier till studerande, forskare, lärare och institutioner.

Closing date: 20 February 2022

Further information 


Projektbidrag för 2023-2025, Centrum för innovativ medicin (CIMED) 

CIMED utlyser projektbidrag för kliniska och translationella projekt för 2023-2025. Bidraget söks av forskare med sin verksamhet knuten till en av institutionerna vid Campus Flemingsberg. Forskningsprojektet ska vara förlagt till Campus Flemingsberg. Utlysningen sker genom Region Stockholms researchweb. Bidragstid är från 1 till 3 år och belopp från 300 000 kr till 1 000 000 kr. 

Closing date: 1 March 2022

Further information


Initiation Grants – The Swedish Foundation for International Cooperation in Research and Higher Education (STINT)

The purpose of STINT’s activity is to strengthen the competitiveness of Swedish universities and colleges through the development of international relationships. The internationalisation of higher education and research is mainly based on concerted, long-term efforts. Sometimes however, it is important to be able to act quickly when the opportunity arises. STINT offers Initiation Grants for this purpose. Initiation grants are given for the implementation of short-term projects targeting the building of new and strategically interesting international relationships. Collaborations with partners outside the EU/EFTA are eligible.

Closing date: 1 March 2022

Further information 


Grants for Teaching Sabbatical s– The Swedish Foundation for International Cooperation in Research and Higher Education (STINT)

The purpose of Grants for Teaching Sabbaticals is to further develop Swedish higher education. STINT wants to contribute to educational renewal and the creation of new networks by giving Swedish researchers and university lecturers, who are passionate about education, international experiences relevant to their teaching role.

Closing date: 17 March 2022

Further information


Intresserad av internationella studier? Sök utlandsstipendium från Hans Werthén Fonden

Har du tänkt vidareutveckla dig utomlands, är cirka 25–35 år, har en akademisk examen lägst på masternivå men gärna doktorsexamen, företrädesvis inom områdena teknik/naturvetenskap eller ekonomi/juridik? Då kan du söka ett stipendium från Hans Werthén Fonden vid Kungl. Ingenjörsvetenskapsakademien, IVA. 

Ansökningsportalen är öppen till den 1 mars 2022. 

Gå in på Iva stipendier och prisereller kontakta Caroline Linden, telefon 08-791 29 51  eller e-post

European calls


Research grant - Cystic Fibrosis Research Foundation | Fondazione Ricerca Fibrosi Cistica, IT

The Italian Cystic Fibrosis Research Foundation invites applications for its research grant. This supports research projects aiming to improve the health status of cystic fibrosis patients. Research projects dealing with either clinical studies or pre-clinical studies exploiting animal models of CF are strongly encouraged. Multi-centre applications that combine different expertise in one project are given a higher priority only if there is evidence that the expected output will be more effective than the sum of individual projects.

Scientists with proven scientific independence and at least three experimental or clinical papers published in the last five years may apply. PIs must have a permanent position and reside in Italy. If PIs and multicentre project co-ordinators live and work in another European country, at least one partner in the project must be resident and work in Italy.

Grants are worth up to €120,000 for two-year projects or €70,000 for one year.

Deadline: by midnight of 15th February 2022

Further information 


Andrew K Burroughs short-term training fellowship. European Association for the Study of the Liver, EUR

The European Association for the Study of the Liver invites applications for the Andrew K Burroughs short-term training fellowship programme. This enables postgraduate investigators, who intend to spend time at a foreign institution in Europe, to accomplish a very focused research project, to learn an experimental procedure or methodology, or to get in-depth knowledge about a sophisticated, clinical diagnostic procedure not available at their home institution.

Members of the association who hold an MD or PhD degree and are no more than 40 years of age may apply. They may be of any nationality and be both basic or clinical investigators. The research supervisor at the hosting institution must be a member of the association but must not be a member of its governing board.

Fellowships are worth total €18 000 (€3,000 per month for up to six months).

Deadline: 29 March 2022

Further information 


EFSD/Boehringer Ingelheim European research programme on multi-system challenges in diabetes. European Association for the Study of Diabetes, EUR

The European Foundation for the Study of Diabetes and Boehringer Ingelheim invite applications for their European research programme on multi-system challenges in diabetes. This supports projects that advance current knowledge in the inter-organ crosstalk and related pathophysiology in diabetes and its complications through innovative basic or clinical research.

Applications are invited from single or groups of non-profit institutions in Europe and associated countries. The PI and any co-investigators must be employed full-time at a non-profit institution, and the study must be conducted at their place of work.

Funding is worth up to €100,000 for basic or clinical research projects with the exclusion of clinical trials. Projects may last for one year or longer. In exceptional cases, up to €300,000 may be considered.

Deadline: 4 April 2022 by 12 noon CET.

Further information 


Grants are worth up to €120,000 for two-year projects or €70,000 for one year.

Call - Research and Innovation actions supporting the implementation of the Mission on Cancer

The goal of the mission on cancer is to improve the lives of more than 3 million people by 2030, through prevention, cure and for those affected by cancer including their families, to live longer and better. The objectives include: Understand; Prevent what is preventable; Optimise diagnostics and treatment; Support quality of life; Ensure equitable access in all aforementioned areas.

Calls open for submission:

Deadline: 26 April 2022

US calls

Federal Funding agencies

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers:


Advancing communication strategies to support future HIV vaccine use (R01, R21 Clinical Trial Optional): NIH

This Funding Opportunity Announcement (FOA) invites applications for Research Project Grants (R01) that will advance novel health communication research designed to inform and support acceptance and uptake of future vaccines that protect against HIV. Research should focus on understanding key drivers for HIV vaccine communication success, communication strategies for engagement of communities placed at greatest risk for acquiring HIV, and/or mitigating the impact and reach of HIV vaccine misinformation. Research applications may leverage HIV vaccine analogs (e.g., COVID-19, HPV, HBV vaccines), so long as they have a primary focus on populations placed at risk for HIV, and/or healthcare settings and providers involved in HIV prevention delivery.

This FOA uses the R01 grant mechanism, while RFA-MH-22-171 uses the R21 mechanism. Applications with preliminary data and/or those including longitudinal analysis, advanced modeling, or large-scale clinical trials should consider using the R01 mechanism. Applicants proposing to conduct exploratory, novel studies that break new ground, extend previous discoveries in new directions or result in novel techniques, models or applications should consider the R21 mechanism.

Deadline: May 10, 2022.

Funding Opportunity Announcement (FOA): RFA-MH-22-170 (R01); RFA-MH-22-171 (R21).

Further information: (R01); (R21).


HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed): NIH

The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics.  Specifically, the focus of this FOA is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. Research supported by this FOA must include rigorous validation studies to demonstrate the robustness of the target as a pain treatment target. This will lower the risk of adopting the target in translational projects to develop small molecules, biologics, natural substances, or devices that interact with this target for new pain treatments. Translational research to develop new medical devices is not the focus of this FOA. Basic science studies of pain and related systems in the body are responsive to this FOA and are encouraged in the context of novel pain therapeutic target discovery.

This FOA is not specific for any one or group of pain conditions. Projects to identify novel targets for acute pain, chronic pain, migraine, other headache disorders, osteoarthritis, diabetic neuropathy, chemotherapy-induced neuropathy, sickle-cell pain, post stroke pain, orofacial pain, etc. will be considered. Projects to identify novel targets for a combination of chronic overlapping pain conditions or for specific pathological conditions will be considered. Projects that seek to identify novel targets in specific populations such as women, children, older adults or other underrepresented groups will also be responsive to this FOA.

Deadline: March 02, 2022, June 02, 2022, October 04, 2022, February 02, 2023 until December 07, 2024.

Funding Opportunity Announcement (FOA): RFA-NS-22-034

Further information


Army Research Office fundamental research – short-term innovative research programme: DoD

The US Department of Defense, under its Army Research Office’s fundamental research broad agency announcement, invites applications for its short-term innovative research programme. This supports rapid, short-term investigations to assess the merit of innovative new concepts in basic research in mechanical sciences, mathematical sciences, electronics, computing science, physics, chemistry, life sciences, materials science, network science and environmental sciences. Proposals are expected to be for cutting-edge innovative research that could produce discoveries that would have a significant impact on enabling new and improved army operational capabilities and related technologies.

Grants are worth up to USD 60,000 each.

Deadline: March 31, 2022 

Funding Opportunity Announcement (FOA): W911NF-17-S-0002-04

Further information



Lupus mechanisms and targets award- Lupus Research Alliance, US

The Lupus Research Alliance invites applications for its lupus mechanisms and targets award. This supports research focused on the identification and investigation of molecular pathways or targets that will lead to new or improved therapies for patients with lupus.

The goals of this award are to:

•characterise key steps in the pathogenesis of the disease that will allow for the development of new therapeutic agents;

•promote basic and clinical research studies to identify or better characterise promising lead compounds for lupus treatment;

•support research that facilitates the clinical evaluation of innovative approaches to the prevention, management or treatment of lupus and its complications.

Research that applies knowledge gained in other disease areas, such as other autoimmune and inflammatory conditions, cancer or metabolic diseases, to mechanisms relevant to lupus are encouraged.


  • Letter of Intent Due Date: March 1, 2022
  • Full Application Due Date: August 1, 2022
  • Earliest Start Date: March 2023

Further information 


Irvington postdoctoral fellowships- Cancer Research Institute -US

The Cancer Research Institute invites applications for the Irvington postdoctoral fellowships. These support young scientists at universities and research centres worldwide who wish to receive training in cancer immunology. Projects should be hypothesis driven, mechanistic studies in both immunology and tumour immunology that directly impact understanding of the immune system’s role in cancer.

Applicants must be working in areas directly related to immunology or cancer immunology. They must have a doctoral degree and less than five years’ relevant postdoctoral experience, with the exception of MD applicants. Projects must be conducted under a sponsor who holds a formal appointment at the host institution. There are no citizenship restrictions.

Fellowships are worth USD 175,500 each over three years. Funding may cover salary, health insurance, travel expenses and other research-related costs.

Deadline: 1 April 2022

Further information 


Visionary grants- American Psychological Association- US

The American Psychological Association invites applications for its visionary grants. These support research, education and intervention projects and programmes that use psychology to solve social problems. The priority areas are:

•applying psychology to at-risk, vulnerable populations;

•preventing violence;

•understanding the connection between behaviour and health;

•understanding and eliminating stigma and prejudice;

•EnVISION Anti-Racism Campaign – grants to fund exploration of the cognitive and behavioural parameters that motivate racist feelings and behaviours.

Preference is given to pilot projects that, if successful, would be strong candidates for support from major federal and foundation funding agencies, and to demonstration projects that promise to generalise broadly to similar settings in other geographical areas and to other settings.

Applicants must be graduate students or early-career researchers who have received their doctorate no more than 10 years prior to application. They must also be affiliated with a non-profit charitable, educational or scientific institution, or government entity operating exclusively for charitable and educational purposes.

Grants are each worth up to USD 20,000 for one year.

Deadline: 1 April 2022

Further information 


Breakthrough prizes in life sciences - Breakthrough Initiatives- US

Breakthrough Initiatives, with support from other foundations, invites nominations for its breakthrough prizes in life sciences. These recognise accomplishments in life sciences broadly defined, covering relevant transformative advances toward understanding living systems and extending human life. One prize is allocated each year for work contributing to the understanding of Parkinson’s disease and neurodegenerative disorders.

Individuals of any age may be nominated. There are no age restrictions for nominees and a person can receive a prize more than once. Anyone can nominate a candidate but self-nominations are not allowed.

Up to four prizes, worth USD 3 million each, are available.

Deadline: 1 April 2022

Further information


Engagement award – capacity building - Patient-Centred Outcomes Research Institute -US

The Patient-Centred Outcomes Research Institute, under the Eugene Washington engagement awards programme, invites letters of inquiry for its capacity building award. This supports projects that help communities increase their facility with and ability to participate across all phases of the patient-centred outcomes research and comparative clinical effectiveness research process. The aim is to encourage active integration of patients, caregivers, clinicians and other healthcare stakeholders as integral members of the PCOR or CER enterprise.

Any private or public-sector organisation, including non-profit or for-profit research organisations, may apply. Foreign organisations and non-domestic components of US applicant organisations may apply as long as there is demonstrable benefit to the US healthcare system and patient-centred research. Individuals are not permitted to apply.

Awards are worth up to USD 250,000 over two years.


  • Letter of Intent Deadline: April 4, 2022 by 5pm (ET)
  • Application Deadline: By invitation only; Full proposals due July 11, 2022 by 5pm (ET)
  • Earliest Start Date: December 1, 2022

Further information